India Globalization Capital Inc Stock News

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks and look ahead to how the cannabis industry continues to sha

India Globalization Capital, Inc. (AMEX: IGC) revealed the preliminary results of its exploratory endpoints from a Phase 1 clinical trial of a THC-drug to treat Alzheimer’s symptoms. The Phase 1

India Globalization Capital, Inc. (IGC) with the stream of -8.80% also noticed, India Sintx Technologies, Inc. (SINT) encountered a rapid change of -2.23% in the last hour of Fridays trading The post Have a grip on this: India Globalization Capital, Inc. (AMEX:IGC), Sintx Technologies, Inc. (NASDAQ:SINT) appeared first on Stocks Equity .

Geode Capital Management LLC increased its holdings in shares of India Globalization Capital, Inc. (NYSEAMERICAN:IGC) by 3.9% in the second quarter, Holdings Channel reports. The firm owned 272,005 shares of the construction companys stock after acquiring an additional 10,334 shares during the period. Geode Capital Management LLCs holdings in India Globalization Capital were worth $446,000 []

India Globalization Capital, Inc. (NYSEAMERICAN:IGC)s stock price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.00 and traded as high as $1.52. India Globalization Capital shares last traded at $1.44, with a volume of 561,375 shares traded. The stock has a market capitalization of []

POTOMAC, Md.--(BUSINESS WIRE)-- #Alzheimers--Voting on all matters as disclosed on the Def Proxy filed with the SEC on Sep 15'21 were passed at IGC's Annual Meeting of Shareholders on Oct 15'21.

The stock price of India Globalization Capital, Inc. (NYSEAMERICAN: IGC) increased by over 15% pre-market. This is why it happened.

POTOMAC, Md.--(BUSINESS WIRE)-- #Alzheimers--IGC Completes its Phase 1 Clinical Trial on Alzheimer's Patients, Reports Safety and Tolerability.

BETHESDA, Md.--(BUSINESS WIRE)-- #IGCAD1--IGC announces financial results for quarter ended Jun 30, 2021 & completion of Phase 1 clinical trial of IGC-AD1 to alleviate Alzheimer's symptoms.

India Globalization Capital Receives Patent To Treat Alzheimer's With Cannabis Drug

Screen capture via IGC's healthcare subsidiary Hyalolex. "Drops of Clarity" is their just-patented Alzheimer's treatment.

India Globalization Capital (AMEX:IGC) shares are trading higher after the company announced the issuance of a patent for the treatment of Alzheimer's disease using THC.  The company was issued a pat

India Globalization Capital, Inc. (AMEX: IGC) revealed Thursday that it has obtained a patent from the United States Patent and Trademark Office for the treatment of Alzheimer's disease. The paten

Best high-volume penny stocks for your watchlist right now? Check these 4 out The post Highest Volume Penny Stocks to Watch Today?

IGC stock is moving up in a huge way today. The company is finally earning its patent for the treatment of Alzheimer's disease with cannabis.